Hims & Hers Health, Inc. (HIMS) News
Filter HIMS News Items
HIMS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HIMS News Highlights
- For HIMS, its 30 day story count is now at 6.
- Over the past 28 days, the trend for HIMS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- MD are the most mentioned tickers in articles about HIMS.
Latest HIMS News From Around the Web
Below are the latest news stories about HIMS & HERS HEALTH INC that investors may wish to consider to help them evaluate HIMS as an investment opportunity.
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and LossSAN FRANCISCO, December 04, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today unveiled Weight Loss by Hims & Hers, a comprehensive and customizable clinical approach specifically designed to help people achieve their individual weight-loss goals. The company also announced that Craig Primack, MD, FACP, FAAP, FOMA, a pioneer in the field of clinical obesity medicine, has joined the company as SVP of Weight Management. |
5 Telehealth Stocks That Have Nothing But UpsideNavigate the exciting world of telehealth with our curated list of top telehealth stocks. |
It Is Time To Buy Hims & Hers StockHims & Hers is a pharmaceutical marketing, product, and distribution firm with a telehealth component. |
2024’s Hidden Gems: 7 Small-Caps Set for Explosive GrowthSmall-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy |
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 OutlookSAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today reported financial results for the third quarter ended September 30, 2023. |
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program AuthorizationSAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company," NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years. Hims & Hers intends to use the program to repurchase shares on a discretionary basis from time to time, subject to general business and market conditions and other investment opportunit |
Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic ServicesSAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS), the leading health and wellness platform, today introduced MedMatch, a technology designed to transform healthcare by giving providers a more intelligent and informed way to deliver personalized care to patients with more effective and precise treatments and medications. |
Hims & Hers Names Khobi Brooklyn As Chief Communications OfficerSAN FRANCISCO, October 19, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced communications veteran Khobi Brooklyn will further position Hims & Hers at the forefront of personalized healthcare as its Chief Communications Officer. Brooklyn’s extensive communications leadership experience includes roles at global brands such as Tesla, Nike, Square and Aurora. In her role as CCO, Brooklyn will strengthen the Hims & Hers brand and i |
Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023SAN FRANCISCO, October 16, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. |
What healthcare execs are saying on staffing, AI, weight loss drugsThe rising popularity of digital services, artificial intelligence, and weight loss drugs are paving the way for various concerns in the healthcare space. Yahoo Finance Senior Health Reporter Anjalee Khemlani spoke with some of the top health executives at the 2023 HLTH Conference in Las Vegas to gain insights into where these new frontiers for healthcare will lead and what that means for the patient experience. Top interviews include: 0:35 — 1:48 Dr. Vineeta Agarwal, Andreessen Horowitz General Partner 2:09 — 3:17 Dr. Amy Abernathy, Verily Chief Medical Officer 3:41 — 5:40 Neil Lindsay, Amazon (AMZN) Health Services SVP 6:03 — 7:07 Dr. Patrick Carrol, Hims & Hers (HIMS) Chief Medical Officer 7:29 — 8:08 Dr. Jon Wigneswaran, Walmart (WMT) Chief Medical Officer For more expert insight an... |